Skip to main content
Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
13.37
-0.23 (-1.69%)
At close: Mar 9, 2026, 4:00 PM EDT
13.87
+0.50 (3.74%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Arvinas Revenue

In the year 2025, Arvinas had annual revenue of $262.60M, down -0.30%. Arvinas had revenue of $9.50M in the quarter ending December 31, 2025, a decrease of -83.95%.

Revenue (ttm)
$262.60M
Revenue Growth
-0.30%
P/S Ratio
3.26
Revenue / Employee
$1,067,480
Employees
246
Market Cap
855.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025262.60M-800.00K-0.30%
Dec 31, 2024263.40M184.90M235.54%
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MannKind 348.97M
Phathom Pharmaceuticals 175.11M
Xencor 125.58M
CytomX Therapeutics 113.63M
Kura Oncology 67.48M
Evommune 13.00M
Janux Therapeutics 10.00M
KalVista Pharmaceuticals 1.43M
Revenue Rankings

ARVN News

More News